- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02807376
An Evaluation of a Powered Vascular Stapler in Laparoscopic Nephrectomies and Nephroureterectomies
November 29, 2018 updated by: Ethicon Endo-Surgery
A Prospective, Randomized, Controlled, Multi-Center Evaluation of a Powered Vascular Stapler in Laparoscopic Nephrectomies and Nephroureterectomies
This prospective, randomized, controlled, multi-center study will collect and compare data from the surgeon's current standard of care stapler (for renal artery and renal vein transection) and powered vascular stapler
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
270
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Georgia
-
Atlanta, Georgia, United States, 30322
- Emory University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Scheduled for a simple or radical laparoscopic nephrectomy or a laparoscopic nephroureterectomy in accordance with the institution's standard of care (SOC);
- Performance status 0-1 (Eastern Cooperative Oncology Group classification), if applicable;
- American Society of Anesthesiologists (ASA) score < 3;
- No prior history of partial or wedge nephrectomy (on the kidney in which the procedure will be performed);
- Willing to give consent and comply with study-related evaluation and treatment schedule; and
- At least 18 years of age
Exclusion Criteria:
- Prior chemotherapy or radiation (within 30 days prior to the procedure or the duration of the subject's enrollment);
- Pregnancy;
- Physical or psychological condition which would impair study participation; or
- The subject is judged unsuitable for study participation by the Investigator for any other reason.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Surgeon's 'standard of care' stapler
Surgeon's standard of care stapler
|
|
|
Experimental: Ethicon Powered Vascular Stapler
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Proportion of Vessels Transected Requiring Intra-Operative Hemostatic Interventions
Time Frame: Intra-Operative, an average of 2.6 hours, ranging from 42 minutes to 6.4 hours
|
Proportion of hemostatic interventions/procedures completed for intra-operative bleeding related to the transection of the Reanl Artery and Renal Vein during laparoscopic nephrectomy or nephroureterectomy with the use of standard of care stapler (SOC) or powered vascular stapler (PVS) defined as bleeding detected and controlled intraoperatively (additional stapling, over-sewing, clip placement, compression, use of suture, sealant, and/or buttress, and/or use of energy); or bleeding that occurs intra-operatively requiring blood or blood product transfusion or an additional surgical procedure (e.g.
conversion to open).
|
Intra-Operative, an average of 2.6 hours, ranging from 42 minutes to 6.4 hours
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Proportion of Participants Requiring Post-operative Interventions or Procedures Related to Renal Artery or Renal Vein Bleeding
Time Frame: Post-Op through 4 Week Follow-up
|
Proportion of participants with hemostatic interventions /procedures completed for post-operative bleeding related to the transection of the Renal Artery and Renal Vein during laparoscopic nephrectomy or nephroureterectomy with the use of SOC or PVS:
No hemostasis intervention is defined as no interventions needed for post-operative bleeding (related to PA and PV transection). |
Post-Op through 4 Week Follow-up
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
July 5, 2016
Primary Completion (Actual)
August 23, 2017
Study Completion (Actual)
August 23, 2017
Study Registration Dates
First Submitted
June 14, 2016
First Submitted That Met QC Criteria
June 16, 2016
First Posted (Estimate)
June 21, 2016
Study Record Updates
Last Update Posted (Actual)
December 19, 2018
Last Update Submitted That Met QC Criteria
November 29, 2018
Last Verified
November 1, 2018
More Information
Terms related to this study
Other Study ID Numbers
- 15-002
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Excision of Kidney
-
University of California, DavisNot yet recruitingExcision Margin | Mohs Micrographic SurgeryUnited States
-
Assiut UniversityRecruitingSafety of Excision the New Tumor SizeEgypt
-
Imperial College LondonSamanTree Medical SAActive, not recruitingBreast Cancer | Margins of ExcisionUnited Kingdom
-
Fondazione I.R.C.C.S. Istituto Neurologico Carlo...Recruiting
-
Guangdong Provincial People's HospitalNot yet recruitingBreast-Conserving SurgeryChina
-
Semmelweis UniversityNational Institute of Oncology, HungaryCompletedLung | VATS | ICG (Indocyanine Green)Hungary
-
Mansoura UniversityGustave Roussy, Cancer Campus, Grand Paris; West oncologic center, Nantes,...CompletedTotal Mesorectal Excision | LaparoscopicEgypt
-
Sirius Medical Systems B.V.Avania B.V.Not yet recruitingBreast Surgery | Lymph Node ExcisionNetherlands
-
Qian WuCompletedPropofol | Esketamine | Loop Electrosurgical ExcisionChina
-
Ahmed Mohamed AbdelraufCompletedEdema Due to Obstruction of Lymph Vessels or Excision of Lymph NodesEgypt
Clinical Trials on Surgeon's 'standard of care' stapler
-
Ethicon Endo-SurgeryCompletedNon Small Cell Lung CancerUnited States
-
Nanchong Central HospitalPengan County People's Hospital; Nanbu Hospital of County Chinese Medicine; Langzhong... and other collaboratorsRecruitingPostoperative Complications | Gastric Cancer | Gastrostomy | Anastomotic LeakageChina
-
Seoul National University HospitalUnknownColorectal Cancer | Video Information
-
University of MinnesotaAgency for Healthcare Research and Quality (AHRQ)CompletedWound Infection Due to Staphylococcus Aureus | MRSA Infection of Postoperative WoundUnited States
-
brett rasmussenCompleted
-
Indonesia UniversityCompletedCovid19 | AcupunctureIndonesia
-
Aventusoft, LLC.National Heart, Lung, and Blood Institute (NHLBI); Cleveland Clinic FloridaRecruitingHeart Failure (HF)United States
-
Emory UniversityNational Institute of Mental Health (NIMH)Active, not recruitingHiv | Sexual Behavior | Treatment Adherence | Adolescent Behavior | Reproductive Behavior | AIDS | Treatment ComplianceKenya
-
Vascular Biogenics Ltd. operating as VBL TherapeuticsCompletedSevere COVID-19Israel
-
Inonu UniversityUnknownBleeding of the Staple LineTurkey